First Experimental Study of Transference Work - In Teenagers (FEST-IT)
The First Experimental Study on Transference work - In Teenagers (FEST-IT) will be a randomized clinical trial, which will be designed to explore effects of transference work in dynamic psychotherapy in adolescents with MDD. The design of the study is a so-called dismantling design, in which a single component is added and/or varied to an existent treatment method (psychodynamic psychotherapy). Thus, the efficiency of a specific technique (transference interventions) can be identified.
The primary hypothesis is that the transference group may have a more favorable course over time than will the comparison group.
The second hypothesis is that patients with a history of low Quality of Object Relations score and/or lacking personality disorders—might benefit more from therapy with transference work than from therapy without.
The third hypothesis is that female adolescents may have better treatment effect of transference work than male adolescents.
Behavioral: Individual therapy
|Study Design:||Primary Purpose: Treatment|
- Psychodynamic Functioning Scales (PFS)
- Inventory of Interpersonal Problems-Circumplex Version (IIP-C)
- Global Assessment of Functioning (GAF)
- Symptom Checklist-90 (Global Severity Index; GSI)
- Beck Depression Inventory (BDI)
- Montgomery Åsberg Rating Scale (MADRS)
|Study Start Date:||January 2012|
|Estimated Study Completion Date:||September 2028|
|Estimated Primary Completion Date:||September 2017 (Final data collection date for primary outcome measure)|
|Experimental: Transference work||Behavioral: Individual therapy Other: Psychotherapy|
Please refer to this study by its ClinicalTrials.gov identifier: NCT01531101
|Contact: Randi Ulberg, PhD||+ 47 22 02 99 77||Randi.Ulberg@siv.no|
|Contact: Anne Hersoug, Dr.Phil.||+ 47 22 02 99 77||A.G.Hersoug@medisin.uio.no|
|Research Unit, Division of||Recruiting|
|Tønsberg, Vestfold, Norway, 3103|
|Contact: Randi Ulberg, PhD|
|Principal Investigator: Randi Ulberg, PhD|
|Sub-Investigator: Anne Hersoug, Dr.Phil|
|Sub-Investigator: Per Høglend, Dr.med|